Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed

Summary Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are trans...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychoneuroendocrinology 2010-05, Vol.35 (4), p.544-556
Hauptverfasser: Alt, Simone R, Turner, Jonathan D, Klok, Melanie D, Meijer, Onno C, Lakke, Egbert A.J.F, DeRijk, Roel H, Muller, Claude P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 556
container_issue 4
container_start_page 544
container_title Psychoneuroendocrinology
container_volume 35
creator Alt, Simone R
Turner, Jonathan D
Klok, Melanie D
Meijer, Onno C
Lakke, Egbert A.J.F
DeRijk, Roel H
Muller, Claude P
description Summary Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are transcriptionally controlled by multiple untranslated alternative first exons, each with its own promoter providing a mechanism for tissue-specific fine-tuning of GR levels. Recently epigenetic methylation of these GR promoters was shown to modulate hippocampal GR levels. Here we investigate in post-mortem brain tissues whether in MDD HPA axis hyperactivity may be due to epigenetic modulation of GR transcript variants. Levels of GRα, GRβ and GR-P transcripts were homogeneous throughout the limbic system, with GRα being the most abundant (83%), followed by GR-P (5–6%) while GRβ was barely detectable (0.02%). Among the alternative first exons, 1B and 1C were the most active, while 1E and 1J showed the lowest expression and transcript 1F expressed intermediate levels of about 1%. In MDD, total GR levels were unaltered, although GRα was decreased in the amygdala and cingulate gyrus ( p < 0.05); transcripts containing exons 1B, 1C and 1F were lower, and 1D and1J were increased in some regions. NGFI-A, a transcription factor of exon 1F was down-regulated in the hippocampus of MDD patients; concomitantly exon 1F expression was reduced. Bisulphite sequencing of the alternative promoters showed low methylation levels in both MDD and control brains. Promoter 1F was uniformly unmethylated, suggesting that reduced 1F transcript levels are not linked to promoter methylation but to the observed dearth of NGFI-A. Previous studies showed high methylation levels in the 1F promoter, associated with childhood abuse. Provided our donors were not abused, our results suggest that the pathomechanism of MDD is similar but nevertheless distinct from that of abuse victims, explaining the clinical similarity of both conditions and that susceptibility to depression may be either predisposed by early trauma or developed independent of such a condition. However, this should be further confirmed in dedicated studies in larger cohorts.
doi_str_mv 10.1016/j.psyneuen.2009.09.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_744616294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306453009002790</els_id><sourcerecordid>733349519</sourcerecordid><originalsourceid>FETCH-LOGICAL-c537t-a175d633ca7838370013a2bd263f567815b7013f03fe4166abf76f55b4f3b2933</originalsourceid><addsrcrecordid>eNqFkk2LFDEQhoMo7jj6F5ZcxFOPlaQ76b6Isn7Cggf1HNLpypCxJ2mT7sUBf7xpZlTwslAQKJ76yPsWIdcMdgyYfHnYTfkUcMGw4wDdbg1gD8iGtUpUQkh4SDYgQFZ1I-CKPMn5AACylfwxuWKdanmt1Ib8euudw4Rh9mak-HNKmLOPgUZH9-Nio41p9jb6gSa0OM0x0TmZkG3y05ypD_RoDiU54Ln0Dungc0wDJuozDXGmOPk9BixtzDie6JTiPpnjEYen5JEzY8Znl3dLvr1_9_XmY3X7-cOnmze3lW2EmivDVDNIIaxRrWiFKh8VhvcDl8I1UrWs6VVJORAOayal6Z2Srmn62omed0JsyYtz3zL6x4J51kefLY6jCRiXrFVdSyZ5V99PCiHqrmFdIeWZtCnmnNDpKfmjSSfNQK8W6YP-Y5FeLdJrlDW35PoyYumLBv_KLp4U4PkFMLko5ora1ue_HOdN2wCHwr0-c1iku_OYdLYeg8XBF6tmPUR__y6v_mthRx9Wn77jCfMhLikUYzTTmWvQX9aDWu8JOgCuOhC_AbvDylo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733349519</pqid></control><display><type>article</type><title>Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Alt, Simone R ; Turner, Jonathan D ; Klok, Melanie D ; Meijer, Onno C ; Lakke, Egbert A.J.F ; DeRijk, Roel H ; Muller, Claude P</creator><creatorcontrib>Alt, Simone R ; Turner, Jonathan D ; Klok, Melanie D ; Meijer, Onno C ; Lakke, Egbert A.J.F ; DeRijk, Roel H ; Muller, Claude P</creatorcontrib><description>Summary Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are transcriptionally controlled by multiple untranslated alternative first exons, each with its own promoter providing a mechanism for tissue-specific fine-tuning of GR levels. Recently epigenetic methylation of these GR promoters was shown to modulate hippocampal GR levels. Here we investigate in post-mortem brain tissues whether in MDD HPA axis hyperactivity may be due to epigenetic modulation of GR transcript variants. Levels of GRα, GRβ and GR-P transcripts were homogeneous throughout the limbic system, with GRα being the most abundant (83%), followed by GR-P (5–6%) while GRβ was barely detectable (0.02%). Among the alternative first exons, 1B and 1C were the most active, while 1E and 1J showed the lowest expression and transcript 1F expressed intermediate levels of about 1%. In MDD, total GR levels were unaltered, although GRα was decreased in the amygdala and cingulate gyrus ( p &lt; 0.05); transcripts containing exons 1B, 1C and 1F were lower, and 1D and1J were increased in some regions. NGFI-A, a transcription factor of exon 1F was down-regulated in the hippocampus of MDD patients; concomitantly exon 1F expression was reduced. Bisulphite sequencing of the alternative promoters showed low methylation levels in both MDD and control brains. Promoter 1F was uniformly unmethylated, suggesting that reduced 1F transcript levels are not linked to promoter methylation but to the observed dearth of NGFI-A. Previous studies showed high methylation levels in the 1F promoter, associated with childhood abuse. Provided our donors were not abused, our results suggest that the pathomechanism of MDD is similar but nevertheless distinct from that of abuse victims, explaining the clinical similarity of both conditions and that susceptibility to depression may be either predisposed by early trauma or developed independent of such a condition. However, this should be further confirmed in dedicated studies in larger cohorts.</description><identifier>ISSN: 0306-4530</identifier><identifier>EISSN: 1873-3360</identifier><identifier>DOI: 10.1016/j.psyneuen.2009.09.001</identifier><identifier>PMID: 19782477</identifier><identifier>CODEN: PSYCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adult and adolescent clinical studies ; Aged ; Aged, 80 and over ; Alternative transcripts ; Behavioral psychophysiology ; Biological and medical sciences ; Brain - metabolism ; Brain - pathology ; Case-Control Studies ; CpG Islands - genetics ; Depression ; Depressive Disorder, Major - genetics ; Depressive Disorder, Major - metabolism ; Depressive Disorder, Major - pathology ; DNA Methylation ; Endocrinology &amp; Metabolism ; Epigenesis, Genetic - physiology ; Epigenetics ; Female ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation ; Glucocorticoid receptor ; Hormones and behavior ; Humans ; Major depressive disorder ; Male ; Medical sciences ; Middle Aged ; Mood disorders ; mRNA expression ; Protein Isoforms - genetics ; Protein Isoforms - metabolism ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Psychopathology. Psychiatry ; Pyrosequencing ; Receptors, Glucocorticoid - genetics ; Receptors, Glucocorticoid - metabolism ; RNA, Messenger - genetics ; RNA, Messenger - metabolism</subject><ispartof>Psychoneuroendocrinology, 2010-05, Vol.35 (4), p.544-556</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2009 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c537t-a175d633ca7838370013a2bd263f567815b7013f03fe4166abf76f55b4f3b2933</citedby><cites>FETCH-LOGICAL-c537t-a175d633ca7838370013a2bd263f567815b7013f03fe4166abf76f55b4f3b2933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.psyneuen.2009.09.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22585020$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19782477$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alt, Simone R</creatorcontrib><creatorcontrib>Turner, Jonathan D</creatorcontrib><creatorcontrib>Klok, Melanie D</creatorcontrib><creatorcontrib>Meijer, Onno C</creatorcontrib><creatorcontrib>Lakke, Egbert A.J.F</creatorcontrib><creatorcontrib>DeRijk, Roel H</creatorcontrib><creatorcontrib>Muller, Claude P</creatorcontrib><title>Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed</title><title>Psychoneuroendocrinology</title><addtitle>Psychoneuroendocrinology</addtitle><description>Summary Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are transcriptionally controlled by multiple untranslated alternative first exons, each with its own promoter providing a mechanism for tissue-specific fine-tuning of GR levels. Recently epigenetic methylation of these GR promoters was shown to modulate hippocampal GR levels. Here we investigate in post-mortem brain tissues whether in MDD HPA axis hyperactivity may be due to epigenetic modulation of GR transcript variants. Levels of GRα, GRβ and GR-P transcripts were homogeneous throughout the limbic system, with GRα being the most abundant (83%), followed by GR-P (5–6%) while GRβ was barely detectable (0.02%). Among the alternative first exons, 1B and 1C were the most active, while 1E and 1J showed the lowest expression and transcript 1F expressed intermediate levels of about 1%. In MDD, total GR levels were unaltered, although GRα was decreased in the amygdala and cingulate gyrus ( p &lt; 0.05); transcripts containing exons 1B, 1C and 1F were lower, and 1D and1J were increased in some regions. NGFI-A, a transcription factor of exon 1F was down-regulated in the hippocampus of MDD patients; concomitantly exon 1F expression was reduced. Bisulphite sequencing of the alternative promoters showed low methylation levels in both MDD and control brains. Promoter 1F was uniformly unmethylated, suggesting that reduced 1F transcript levels are not linked to promoter methylation but to the observed dearth of NGFI-A. Previous studies showed high methylation levels in the 1F promoter, associated with childhood abuse. Provided our donors were not abused, our results suggest that the pathomechanism of MDD is similar but nevertheless distinct from that of abuse victims, explaining the clinical similarity of both conditions and that susceptibility to depression may be either predisposed by early trauma or developed independent of such a condition. However, this should be further confirmed in dedicated studies in larger cohorts.</description><subject>Adult and adolescent clinical studies</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alternative transcripts</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Case-Control Studies</subject><subject>CpG Islands - genetics</subject><subject>Depression</subject><subject>Depressive Disorder, Major - genetics</subject><subject>Depressive Disorder, Major - metabolism</subject><subject>Depressive Disorder, Major - pathology</subject><subject>DNA Methylation</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Epigenesis, Genetic - physiology</subject><subject>Epigenetics</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation</subject><subject>Glucocorticoid receptor</subject><subject>Hormones and behavior</subject><subject>Humans</subject><subject>Major depressive disorder</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mood disorders</subject><subject>mRNA expression</subject><subject>Protein Isoforms - genetics</subject><subject>Protein Isoforms - metabolism</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Psychopathology. Psychiatry</subject><subject>Pyrosequencing</subject><subject>Receptors, Glucocorticoid - genetics</subject><subject>Receptors, Glucocorticoid - metabolism</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><issn>0306-4530</issn><issn>1873-3360</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2LFDEQhoMo7jj6F5ZcxFOPlaQ76b6Isn7Cggf1HNLpypCxJ2mT7sUBf7xpZlTwslAQKJ76yPsWIdcMdgyYfHnYTfkUcMGw4wDdbg1gD8iGtUpUQkh4SDYgQFZ1I-CKPMn5AACylfwxuWKdanmt1Ib8euudw4Rh9mak-HNKmLOPgUZH9-Nio41p9jb6gSa0OM0x0TmZkG3y05ypD_RoDiU54Ln0Dungc0wDJuozDXGmOPk9BixtzDie6JTiPpnjEYen5JEzY8Znl3dLvr1_9_XmY3X7-cOnmze3lW2EmivDVDNIIaxRrWiFKh8VhvcDl8I1UrWs6VVJORAOayal6Z2Srmn62omed0JsyYtz3zL6x4J51kefLY6jCRiXrFVdSyZ5V99PCiHqrmFdIeWZtCnmnNDpKfmjSSfNQK8W6YP-Y5FeLdJrlDW35PoyYumLBv_KLp4U4PkFMLko5ora1ue_HOdN2wCHwr0-c1iku_OYdLYeg8XBF6tmPUR__y6v_mthRx9Wn77jCfMhLikUYzTTmWvQX9aDWu8JOgCuOhC_AbvDylo</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Alt, Simone R</creator><creator>Turner, Jonathan D</creator><creator>Klok, Melanie D</creator><creator>Meijer, Onno C</creator><creator>Lakke, Egbert A.J.F</creator><creator>DeRijk, Roel H</creator><creator>Muller, Claude P</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>7TM</scope></search><sort><creationdate>20100501</creationdate><title>Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed</title><author>Alt, Simone R ; Turner, Jonathan D ; Klok, Melanie D ; Meijer, Onno C ; Lakke, Egbert A.J.F ; DeRijk, Roel H ; Muller, Claude P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c537t-a175d633ca7838370013a2bd263f567815b7013f03fe4166abf76f55b4f3b2933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alternative transcripts</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Case-Control Studies</topic><topic>CpG Islands - genetics</topic><topic>Depression</topic><topic>Depressive Disorder, Major - genetics</topic><topic>Depressive Disorder, Major - metabolism</topic><topic>Depressive Disorder, Major - pathology</topic><topic>DNA Methylation</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Epigenesis, Genetic - physiology</topic><topic>Epigenetics</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation</topic><topic>Glucocorticoid receptor</topic><topic>Hormones and behavior</topic><topic>Humans</topic><topic>Major depressive disorder</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mood disorders</topic><topic>mRNA expression</topic><topic>Protein Isoforms - genetics</topic><topic>Protein Isoforms - metabolism</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Psychopathology. Psychiatry</topic><topic>Pyrosequencing</topic><topic>Receptors, Glucocorticoid - genetics</topic><topic>Receptors, Glucocorticoid - metabolism</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alt, Simone R</creatorcontrib><creatorcontrib>Turner, Jonathan D</creatorcontrib><creatorcontrib>Klok, Melanie D</creatorcontrib><creatorcontrib>Meijer, Onno C</creatorcontrib><creatorcontrib>Lakke, Egbert A.J.F</creatorcontrib><creatorcontrib>DeRijk, Roel H</creatorcontrib><creatorcontrib>Muller, Claude P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><jtitle>Psychoneuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alt, Simone R</au><au>Turner, Jonathan D</au><au>Klok, Melanie D</au><au>Meijer, Onno C</au><au>Lakke, Egbert A.J.F</au><au>DeRijk, Roel H</au><au>Muller, Claude P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed</atitle><jtitle>Psychoneuroendocrinology</jtitle><addtitle>Psychoneuroendocrinology</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>35</volume><issue>4</issue><spage>544</spage><epage>556</epage><pages>544-556</pages><issn>0306-4530</issn><eissn>1873-3360</eissn><coden>PSYCDE</coden><abstract>Summary Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are transcriptionally controlled by multiple untranslated alternative first exons, each with its own promoter providing a mechanism for tissue-specific fine-tuning of GR levels. Recently epigenetic methylation of these GR promoters was shown to modulate hippocampal GR levels. Here we investigate in post-mortem brain tissues whether in MDD HPA axis hyperactivity may be due to epigenetic modulation of GR transcript variants. Levels of GRα, GRβ and GR-P transcripts were homogeneous throughout the limbic system, with GRα being the most abundant (83%), followed by GR-P (5–6%) while GRβ was barely detectable (0.02%). Among the alternative first exons, 1B and 1C were the most active, while 1E and 1J showed the lowest expression and transcript 1F expressed intermediate levels of about 1%. In MDD, total GR levels were unaltered, although GRα was decreased in the amygdala and cingulate gyrus ( p &lt; 0.05); transcripts containing exons 1B, 1C and 1F were lower, and 1D and1J were increased in some regions. NGFI-A, a transcription factor of exon 1F was down-regulated in the hippocampus of MDD patients; concomitantly exon 1F expression was reduced. Bisulphite sequencing of the alternative promoters showed low methylation levels in both MDD and control brains. Promoter 1F was uniformly unmethylated, suggesting that reduced 1F transcript levels are not linked to promoter methylation but to the observed dearth of NGFI-A. Previous studies showed high methylation levels in the 1F promoter, associated with childhood abuse. Provided our donors were not abused, our results suggest that the pathomechanism of MDD is similar but nevertheless distinct from that of abuse victims, explaining the clinical similarity of both conditions and that susceptibility to depression may be either predisposed by early trauma or developed independent of such a condition. However, this should be further confirmed in dedicated studies in larger cohorts.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>19782477</pmid><doi>10.1016/j.psyneuen.2009.09.001</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4530
ispartof Psychoneuroendocrinology, 2010-05, Vol.35 (4), p.544-556
issn 0306-4530
1873-3360
language eng
recordid cdi_proquest_miscellaneous_744616294
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult and adolescent clinical studies
Aged
Aged, 80 and over
Alternative transcripts
Behavioral psychophysiology
Biological and medical sciences
Brain - metabolism
Brain - pathology
Case-Control Studies
CpG Islands - genetics
Depression
Depressive Disorder, Major - genetics
Depressive Disorder, Major - metabolism
Depressive Disorder, Major - pathology
DNA Methylation
Endocrinology & Metabolism
Epigenesis, Genetic - physiology
Epigenetics
Female
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation
Glucocorticoid receptor
Hormones and behavior
Humans
Major depressive disorder
Male
Medical sciences
Middle Aged
Mood disorders
mRNA expression
Protein Isoforms - genetics
Protein Isoforms - metabolism
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Psychopathology. Psychiatry
Pyrosequencing
Receptors, Glucocorticoid - genetics
Receptors, Glucocorticoid - metabolism
RNA, Messenger - genetics
RNA, Messenger - metabolism
title Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A34%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20expression%20of%20glucocorticoid%20receptor%20transcripts%20in%20major%20depressive%20disorder%20is%20not%20epigenetically%20programmed&rft.jtitle=Psychoneuroendocrinology&rft.au=Alt,%20Simone%20R&rft.date=2010-05-01&rft.volume=35&rft.issue=4&rft.spage=544&rft.epage=556&rft.pages=544-556&rft.issn=0306-4530&rft.eissn=1873-3360&rft.coden=PSYCDE&rft_id=info:doi/10.1016/j.psyneuen.2009.09.001&rft_dat=%3Cproquest_cross%3E733349519%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733349519&rft_id=info:pmid/19782477&rft_els_id=S0306453009002790&rfr_iscdi=true